Alterity Therapeutics logo

Alterity Therapeutics

ATHE | NASDAQ
Chart Builder DCF Calculator
$1.96
$0.00 (0.00%)
At close: Nov 16, 2026, 4:00 PM ET
$1.96
$0.00 (0.00%)
After-hours: Nov 16, 2026, 4:10 PM ET
+0.00%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
32.5
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #728/1021 (Top 71%)

Key Statistics

Market Data

Market Cap $35.53M
1D Range
1.89 1.96
52W Range
1.89 5.89

Valuation (TTM)

PE -2.19
PB 1.20
EV/EBITDA -0.50

Valuation (NTM)

Forward PE N/A
Forward PEG 0.06
Price Target $10.00
Loading financial charts...

Profile

Alterity Therapeutics Limited, an Australian biopharmaceutical firm, focuses on the discovery and development of novel drug treatments for various neurological disorders, such as Alzheimer's, Huntingt...

Sector Healthcare
Industry Biotechnology
Employees 11
IPO Date Sep 29, 2003
Fiscal Year July - June

Latest News

No news articles available yet.

Earnings

Next Earnings
Mar 4, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.